Skip to content

Dr Adi Hoess brings over two decades of experience in biotechnology.

Dr Adi Hoess

Chief Executive Officer

Dr Adi Hoess brings over two decades of experience in biotechnology, having previously served as CEO of Affimed N.V., where he was instrumental in advancing immuno-oncology therapies and securing multiple industry partnerships. He has a strong track record in leading companies through clinical development to commercialisation, both in Europe and the US.

A medical doctor with a PhD from the University of Munich, Dr Hoess has deep expertise in product development, regulatory approvals, and intellectual property management. His extensive network within the biotech and pharmaceutical sectors has been key in fostering collaborations and securing funding.

Back To Top